NCT07382778

Efficacy and Safety of Livalozet® in Hypercholesterolemic Patients With and Without Diabetes

A Multi-center, Open-label, Observational Study to Compare and Evaluate the Efficacy and Safety of Livalozet® According to the Presence or Absence of Diabetes Mellitus in Hypercholesterolemia Patients

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 1,538 (actual)
• Sponsor: JW Pharmaceutical · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Not accepted

Summary

A Multi-center, Open-label, Observational Study to Compare and Evaluate the Efficacy and Safety of Livalozet® according to the Presence or Absence of Diabetes Mellitus in Hypercholesterolemia Patients

Detailed description

A Multi-center, Open-label, Observational Study

Conditions

• Hypercholesterolemia

Timeline

• Start date: 2022-10-19
• Primary completion: 2025-06-13
• Completion: 2025-06-13
• First posted: 2026-02-03
• Last updated: 2026-02-03

Locations

1 site across 1 country: South Korea